Norwich Research Park is set to build a number of new laboratories and office accommodation after announcing a major investment partnership. 

The city research and innovation campus has entered the investment partnership with real estate investment manager Vengrove.

It will cater to the evolving needs of both current and prospective tenants at the cluster, supporting research breakthroughs in sectors such as agribiotech, food biotech, industrial biotech, medtech.

The site includes the Earlham Institute, John Innes Centre, Quadram Institute Bioscience and The Sainsbury Laboratory, as well as the University of East Anglia (UEA) and Norwich University Hospital. 

READ MORE: Research park's secret to attracting scientists from around the world

Roz Bird, CEO of Anglia Innovation Partnership, the organisation that manages Norwich Research Park, said the investment partnership is a "significant milestone" for the research campus.

Roz Bird, chief executive of Anglian Innovation Partnership LLP, the organisation that manages Norwich Research ParkRoz Bird, chief executive of Anglian Innovation Partnership LLP, the organisation that manages Norwich Research Park (Image: Supplied) "It will enable us to activate existing planning consent and supply new, flexible laboratory and office accommodation to meet market demand," she said.

“With the park full of exciting high-growth companies, the time is right to create new accommodation that will be needed to meet the demands of growing companies and help attract and retain companies that want to benefit from being located at Norwich Research Park.

“With national asset status in engineering biology, and now with access to the necessary real estate investment, Norwich Research Park’s growth trajectory is ensured.”

READ MORE: How a 'draconian' water shortage zone is crippling business in the region

Norwich Research ParkNorwich Research Park (Image: News Quest) Norwich Research park is one of only five research and innovation campuses in the UK supported by the UKRI Biotechnology and Biological Sciences Research Council (BBSRC), which is investing £163.9m into the Earlham Institute, John Innes Centre and Quadram Institute Bioscience until 2028.

UK Research and Innovation (UKRI), backed by its infrastructure fund, has also committed £317m of investment in Norwich Research Park to establish a pioneering plant and microbial research hub by 2030.

Norwich Research Park hosts a community of more than 30,000 members.